Abstract:Vaccine administration via the oral route is preferable to parenteral routes due to ease of administration. To date, most available oral vaccines comprises of live attenuated pathogens as oppose to peptide-based vaccines due to its low bioavailability within the gastrointestinal (GI) tract. Over the years, probiotic-based peptide delivery vehicles comprising of lactic acid bacteria such as Lactococcus lactis has emerged as an interesting alternative due to its generally recognized as safe (GRAS) status, a fully sequenced genome, transient gut colonization time, and is an efficient cellular factory for heterologous protein production. However, its survivability through the GI tract is low, thus better delivery approaches are being explored to improve its bioavailability. In this study, we employ the incorporation of a double coated mucoadhesive film consisting of sodium alginate and Lycoat RS 720 film as the inner coat. The formulated film exhibits good mechanical properties of tensile strength and percent elongation for manipulation and handling with an entrapment yield of 93.14±2.74%. The formulated mucoadhesive film is subsequently loaded into gelatin capsules with an outer enteric Eudragit L100-55 coating capable of a pH-dependent breakdown above pH 5.5 to protect against gastric digestion. The final product and unprotected controls were subjected to in vitro simulated gastrointestinal digestions to assess its survivability. The product demonstrated enhanced protection with an increase of 69.22±0.67% (gastric) and 40.61±8.23% (intestinal) survivability compared to unprotected controls after 6 hours of sequential digestion. This translates to a 3.5 fold increase in overall survivability. Owing to this, the proposed oral delivery system has shown promising potential as a live gastrointestinal vaccine delivery host. Further studies involving in vivo gastrointestinal survivability and mice immunization tests are currently being carried out to assess the efficacy of this novel oral delivery system in comparison to parenteral routes.

A Novel Oral Vaccine Delivery System for Enhancing Stability and Immune Protection: Bacterium-Like Particle with Functional Coating

A novel bacterium-like particles platform displaying antigens by new anchoring proteins induces efficacious immune responses

Bacterium-like particles derived from probiotics: progress, challenges and prospects

Proof of Concept in Utilizing the Peptidoglycan Skeleton of Pathogenic Bacteria As Antigen Delivery Platform for Enhanced Immune Response

Single-Cell Oral Delivery Platform for Enhanced Acid Resistance and Intestinal Adhesion

Promoting Immune Efficacy of the Oral Helicobacter Pylori Vaccine by HP55/PBCA Nanoparticles Against the Gastrointestinal Environment

Acidified sucralfate encapsulated chitosan derivative nanoparticles as oral vaccine adjuvant delivery enhancing mucosal and systemic immunity

Enhanced gastrointestinal survivability of recombinant Lactococcus lactis using a double coated mucoadhesive film approach

Novel intranasal pertussis vaccine based on bacterium-like particles as a mucosal adjuvant.

Advanced Oral Vaccine Delivery Strategies for Improving the Immunity

Nano and Microparticles as Potential Oral Vaccine Carriers and Adjuvants Against Infectious Diseases

Simple Nanoliposomes Encapsulating Lycium Barbarum Polysaccharides As Adjuvants Improve Humoral and Cellular Immunity in Mice

Advancedoral vaccine delivery strategies for improving the immunity.

Enhanced paracellular delivery of vaccine by hydrogel microparticles-mediated reversible tight junction opening for effective oral immunization

Oral Delivery of Novel Recombinant Lactobacillus Elicit High Protection Against Staphylococcus Aureus Pulmonary and Skin Infections

Investigation of 3D Ordered Macroporous Carbon with Different Polymer Coatings and Their Application As an Oral Vaccine Carrier

Enhanced immunization via dissolving microneedle array-based delivery system incorporating subunit vaccine and saponin adjuvant

Enhancing protective immunity against bacterial infection via coating nano‐Rehmannia glutinosa polysaccharide with outer membrane vesicles

Enhanced Oral Vaccine Efficacy of Polysaccharide-Coated Calcium Phosphate Nanoparticles

Formulation Attributes Impact Immune Profile of an Oral and Thermostable COVID-19 Subunit Vaccine

Broad Protective Immune Responses Elicited by Bacterium-Like Particle-Based Intranasal Pneumococcal Particle Vaccine Displaying PspA2 and PspA4 Fragments.